| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |